The cannabis withdrawal syndrome

@article{Budney2006TheCW,
  title={The cannabis withdrawal syndrome},
  author={Alan J. Budney and John R Hughes},
  journal={Current Opinion in Psychiatry},
  year={2006},
  volume={19},
  pages={233–238}
}
Purpose of review The demand for treatment for cannabis dependence has grown dramatically. The majority of the people who enter the treatment have difficulty in achieving and maintaining abstinence from cannabis. Understanding the impact of cannabis withdrawal syndrome on quit attempts is of obvious importance. Cannabis, however, has long been considered a ‘soft’ drug, and many continue to question whether one can truly become dependent on cannabis. Skepticism is typically focused on whether… Expand
Pharmacological treatment of cannabis dependence.
TLDR
Results from controlled human laboratory studies and small open-label clinical trials suggest that dronabinol, the COMT inhibitor entacapone, and lithium may warrant further study and controlled clinical trials are needed to evaluate the clinical efficacy of these medications. Expand
The cannabis withdrawal syndrome: current insights
TLDR
The cannabis withdrawal syndrome (CWS) is a criterion of cannabis use disorders (CUDs) (Diagnostic and Statistical Manual of Mental Disorders – Fifth Edition) and cannabis dependence (ICD]-10 and the up-to-date ICD-11 Beta Draft is recommended to be expanded by physical CWS symptoms, the specification of CWS intensity and duration as well as gender effects. Expand
A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms
TLDR
The findings demonstrate that the use of dronabinol, nabilone, or nabiximols, either alone or in combination with other drugs, shows promise in reducing cannabis withdrawal symptoms, probably with a dose-dependent effect. Expand
Potential Pharmacotherapies for Cannabis Dependence
TLDR
This chapter reviews data from recent research on cannabinoids that may be relevant for the development of pharmacotherapies for cannabis dependence and assesses the effects of potential cannabis treatment medications on cannabinoid-related physiological, subjective, and reinforcing effects. Expand
Treatment of Cannabis Withdrawal Syndrome Using Cognitive-Behavioral Therapy and Relapse Prevention for Cannabis Dependence
Cannabis is the most frequently used illegal substance in the United States and Europe. There is a dramatic increase in the demand for treatment for cannabis dependence. The majority ofExpand
State of the art treatments for cannabis dependence.
TLDR
There is a need for a continuing care model with long-term follow-up that extends past the periods typically evaluated in treatment studies and for further investigation of genetic underpinnings and endophenotypes underlying cannabis dependence to identify neurobiological mechanisms for targeted intervention. Expand
Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review
TLDR
Evidence has shown a decrease in the age of commencement of cannabis use in some developed countries and a prolongation of risk of initiation to cannabis use beyond adolescence among more recent users. Expand
Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study
TLDR
Evidence is provided for the potential clinical utility and safety of lithium in the management of cannabis withdrawal in treatment seeking adult humans and a randomised, placebo-controlled trial is recommended. Expand
An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use
TLDR
Current scientific data and clinical observation strongly support the contention that cannabis use, like the use of other substances such as alcohol, opioids, stimulants, and tobacco, can develop into a use disorder (addiction) with important clinical consequences. Expand
Cannabis Withdrawal: a Review of Neurobiological Mechanisms and Sex Differences
TLDR
Pre-clinical and clinical research on the etiology and biological substrates of the cannabis withdrawal syndrome are provided, and females have been shown to have increased rate and severity of a subset of cannabis withdrawal symptoms compared with men. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 59 REFERENCES
Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies.
  • C. Hart
  • Medicine
  • Drug and alcohol dependence
  • 2005
TLDR
Data from recent research on cannabinoids that may be relevant for the development of pharmacotherapies for cannabis dependence are reviewed because these data may provide information critical for informing relapse prevention medication development efforts. Expand
Development and Consequences of Cannabis Dependence
TLDR
Clinical trials evaluating treatments for cannabis dependence suggest that this disorder, like other substance dependence disorders, is responsive to intervention, yet the majority of patients have difficulty achieving and maintaining abstinence. Expand
Cannabis withdrawal in adolescent treatment seekers.
TLDR
Adolescents presenting for outpatient substance abuse treatment, whose primary substance of abuse was cannabis, completed a questionnaire reporting the presence and severity of withdrawal symptoms during past periods of cannabis abstinence, and the magnitude of withdrawal severity was positively correlated with current emotional and behavioral symptoms and self-reported problems with cannabis use. Expand
Review of the validity and significance of cannabis withdrawal syndrome.
TLDR
Converging evidence from basic laboratory and clinical studies indicates that a withdrawal syndrome reliably follows discontinuation of chronic heavy use of cannabis or tetrahydrocannabinol, and findings suggest that the syndrome has clinical importance. Expand
A cross-study comparison of cannabis and tobacco withdrawal.
TLDR
Descriptive and graphic comparisons indicate that the magnitude and time course of withdrawal effects are similar across the two syndromes. Expand
Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders.
TLDR
The data indicate that for adolescents with conduct problems cannabis use is not benign, and that the drug potently reinforces cannabis-taking, producing both dependence and withdrawal, however, findings from this severely affected clinical population should not be generalized broadly to all other adolescents. Expand
CLINICAL STUDIES OF CANNABIS TOLERANCE AND DEPENDENCE *
TLDR
After a comprehensive review of various aspects of cannabis tolerance and dependence, Wikler thinks the evidence indicates that botholerance and dependence can develop in man. Expand
The time course and significance of cannabis withdrawal.
TLDR
A withdrawal pattern was observed for aggression, anger, anxiety, decreased appetite, decreased body weight, irritability, restlessness, shakiness, sleep problems, and stomach pain that likely contribute to the development of dependence and difficulty stopping use. Expand
Clinical Relevance of Cannabis Tolerance and Dependence
TLDR
Cannabis‐induced super sensitivity should be considered wherever chronic drug administration is anticipated in conditions like epilepsy, glaucoma or chronic pain, and ways of minimizing tolerance and dependence problems are suggested. Expand
Marijuana Withdrawal Syndrome in the Animal Model
TLDR
The results of other genetically altered mouse models suggest the existence of a reciprocal relationship between cannabinoid and opioid systems in drug dependence and will play pivotal roles in further characterizing cannabinoid dependence and elucidating the mechanisms of action. Expand
...
1
2
3
4
5
...